NCT06977165View on ClinicalTrials.gov

Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis

Not yet recruitingOBSERVATIONAL
Enrollment

119

Participants

Timeline

Start Date

September 1, 2025

Primary Completion Date

June 30, 2027

Study Completion Date

September 30, 2027

Conditions
Respiration DisordersRespiratory FailureSepsisInfection in ICUPneumonia
Interventions
DIAGNOSTIC_TEST

Antibiotic quantification

Piperacillin/tazobactam quantification using liquid chromatography-tandem mass spectrometry

Trial Locations (1)

M13 9PL

The University of Manchester, Manchester

All Listed Sponsors
lead

University of Manchester

OTHER

NCT06977165 - Investigating the Impact of Sepsis Phenotypes on Antibiotic Treatment in Patients With Severe Pneumonia and Sepsis | Biotech Hunter | Biotech Hunter